What is the interpretation and recommended next steps for a CBC showing low red blood cell count with normal hemoglobin and hematocrit, macrocytosis, normal other red‑cell indices, normal platelet count and volume, and a white‑cell differential that is essentially normal except for mild monocytosis and slightly low eosinophils?

Macrocytic Anemia with Mild Monocytosis: Workup and Management

This patient has macrocytosis (MCV 107 fL) with borderline low RBC count but preserved hemoglobin/hematocrit, requiring immediate evaluation for vitamin B12 and folate deficiency, followed by assessment for myelodysplastic syndrome (MDS), medication effects, and alcohol use.

Primary Interpretation

The CBC shows macrocytic anemia (MCV >100 fL) with a slightly low RBC count (4.38 × 10^6/μL) but normal hemoglobin (15.0 g/dL) and hematocrit (46.9%). This pattern suggests early or compensated macrocytosis where the larger cell size maintains adequate oxygen-carrying capacity despite reduced cell numbers 1.

The mild monocytosis (13.7%, absolute 0.59 × 10^3/μL) and low eosinophils are likely incidental findings but warrant consideration in the broader clinical context.

Immediate Next Steps

Essential Laboratory Workup

Order the following tests immediately 2:

• Reticulocyte count (corrected for anemia/reticulocyte index): This distinguishes between decreased RBC production versus increased destruction/loss 1

  • Low reticulocyte index (<1.0-2.0): Suggests production defect from B12/folate deficiency, bone marrow dysfunction, or MDS
  • High reticulocyte index: Would suggest hemolysis or blood loss (less likely given this presentation)

• Vitamin B12 level: Most macrocytic anemia is megaloblastic from B12 deficiency 1

• Folate level: Second most common cause of megaloblastic macrocytosis 1

• Peripheral blood smear review: Critical to confirm RBC size, identify hypersegmented neutrophils (B12/folate deficiency), or dysplastic features (MDS) 1

• Thyroid-stimulating hormone (TSH): Hypothyroidism causes non-megaloblastic macrocytosis 2

• Liver function tests: Liver disease is a common cause of macrocytosis 1

Clinical History Priorities

Focus your history on these specific elements:

• Alcohol consumption: Quantify drinks per week (alcoholism causes non-megaloblastic macrocytosis) 1
• Medication review: Specifically ask about hydroxyurea, azathioprine, 6-mercaptopurine, methotrexate, anticonvulsants (phenytoin), antiretrovirals 1, 2
• Neurologic symptoms: Paresthesias, balance problems, cognitive changes (B12 deficiency) 1
• Dietary history: Vegan diet, malabsorption symptoms (B12/folate deficiency)
• Gastrointestinal symptoms: Diarrhea, prior gastric surgery (affects B12 absorption)
• Fatigue severity: Distinguish from normal tiredness 1

Physical Examination Focus

Look specifically for:

• Jaundice: Suggests hemolysis or liver disease 1
• Glossitis: B12/folate deficiency
• Neurologic examination: Posterior column signs, peripheral neuropathy (B12 deficiency)
• Splenomegaly: Hemolysis or hematologic malignancy 1

Algorithmic Approach Based on Results

If B12 or Folate Deficiency Confirmed:

• Treat the deficiency with appropriate supplementation
• Investigate the cause: Pernicious anemia (intrinsic factor antibodies), dietary insufficiency, malabsorption
• Recheck CBC in 4-8 weeks to confirm response

If B12/Folate Normal and No Clear Cause:

This represents unexplained macrocytosis, which carries an 11.6% risk of developing primary bone marrow disorders (MDS, lymphoma) over 4 years 3.

Management strategy 3:

• Bone marrow biopsy should be performed now if any cytopenias are present (you have borderline low RBC count), as this provides 75% diagnostic yield versus 33% without anemia
• If you defer biopsy initially, monitor CBC every 6 months
• Median time to first cytopenia: 18 months
• Mean time to bone marrow disorder diagnosis: 31.6 months
• Perform bone marrow biopsy immediately if new cytopenias develop

If Medication-Related:

• Consider alternative medications if possible
• Monitor CBC regularly while continuing the offending agent

Critical Pitfalls to Avoid

1. Don't dismiss "borderline" findings: Your RBC count is technically low, and macrocytosis with any cytopenia warrants closer investigation 3

2. Don't assume alcohol or medications without confirmation: 11.6% of unexplained macrocytosis develops into serious bone marrow disorders 3

3. Don't delay peripheral smear review: This is the single most important test to guide further workup and can identify dysplastic features suggesting MDS 1, 2

4. Don't ignore the RDW: Your RDW is 14.7% (upper limit 14.9%), suggesting some variation in cell size that may indicate mixed deficiency or early bone marrow dysfunction 2

5. Don't forget that normal hemoglobin doesn't exclude significant pathology: The macrocytosis is compensating for low RBC count, but this may represent early disease 3

Regarding the Monocytosis and Low Eosinophils

The mild monocytosis (13.7%) with absolute count still normal (0.59 × 10^3/μL) is likely reactive but should be reassessed with repeat CBC. The low eosinophils (0.7%, absolute 0.03) are minimally decreased and typically not clinically significant in isolation. However, if bone marrow biopsy is performed for macrocytosis evaluation, these findings will be contextualized.

The priority remains establishing the cause of macrocytosis, as this has the greatest impact on morbidity and mortality through early detection of treatable deficiencies or serious bone marrow disorders 3.